Its revenue totaled $401.6 million in Q3, up 77% year-over-year, per the companys latest earnings report
As demand for effective and reliable weight-loss solutions grows, Novos ability to deliver strong efficacy, consistent availability, and improved affordability positions it ahead of Eli Lilly in the obesity treatment market
Healthy Lifestyle Although GLP-1 reduces appetite and promotes weight loss, effectiveness depends on combination with "a healthy diet and regular exercise." GLP-1 injections are contraindicated for individuals who: "You should ALWAYS consult with your medical provider to determine if GLP-1 injections are safe and appropriate." GLP-1 injections present "a promising option for those seeking effective weight loss when supported with lifestyle changes." Healthcare provider consultation remains essential before initiating treatment
Retatrutide is a triple agonist (GIP, GLP-1, and glucagon)
This single compound can reduce inflammation and oxidative stress, speed the healing of tendons and ligaments, support nerve repair and even improve gut integrity